- Home
- TSHA vs GRNT Comparison
TSHA vs GRNT Comparison
Compare TSHA & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- GRNT
- Stock Information
- Founded
- TSHA 2019
- GRNT 2013
- Country
- TSHA United States
- GRNT United States
- Employees
- TSHA N/A
- GRNT N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- GRNT Blank Checks
- Sector
- TSHA Health Care
- GRNT Finance
- Exchange
- TSHA Nasdaq
- GRNT Nasdaq
- Market Cap
- TSHA 728.4M
- GRNT 752.6M
- IPO Year
- TSHA 2020
- GRNT N/A
- Fundamental
- Price
- TSHA $2.46
- GRNT $6.35
- Analyst Decision
- TSHA Strong Buy
- GRNT Buy
- Analyst Count
- TSHA 7
- GRNT 2
- Target Price
- TSHA $7.57
- GRNT $7.50
- AVG Volume (30 Days)
- TSHA 5.2M
- GRNT 550.9K
- Earning Date
- TSHA 08-11-2025
- GRNT 08-07-2025
- Dividend Yield
- TSHA N/A
- GRNT 6.86%
- EPS Growth
- TSHA N/A
- GRNT N/A
- EPS
- TSHA N/A
- GRNT 0.09
- Revenue
- TSHA $7,224,000.00
- GRNT $390,665,000.00
- Revenue This Year
- TSHA N/A
- GRNT $30.32
- Revenue Next Year
- TSHA N/A
- GRNT $7.79
- P/E Ratio
- TSHA N/A
- GRNT $71.13
- Revenue Growth
- TSHA N/A
- GRNT 6.26
- 52 Week Low
- TSHA $1.05
- GRNT $4.52
- 52 Week High
- TSHA $3.31
- GRNT $7.10
- Technical
- Relative Strength Index (RSI)
- TSHA 45.90
- GRNT 67.39
- Support Level
- TSHA $2.48
- GRNT $5.99
- Resistance Level
- TSHA $2.66
- GRNT $6.22
- Average True Range (ATR)
- TSHA 0.21
- GRNT 0.18
- MACD
- TSHA -0.06
- GRNT 0.01
- Stochastic Oscillator
- TSHA 10.14
- GRNT 90.08
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.